// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A regional audit of the investigation and management of giant cell arteritis

Jayne Little - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

What factors predict good patient experiences of switching from reference etanercept to an etanercept biosimilar in a South West London general hospital?

Laura Attipoe - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Etanercept biosimilar

Audit of the clinical efficacy and safety of etanercept biosimilar to its reference product in patients with inflammatory arthritis: experience from a district general hospital in the United Kingdom

Jianfei Ma - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Etanercept biosimilar

Personalising care: the use of anti-drug antibodies and drug trough levels is a safe and cost-effective treatment strategy in spondyloarthritis

S R Dubash - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Spondyloarthritis

Infliximab

Rheumatology referrals in a district general hospital: the cost of delay

Ayaan Farah - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A review of the outcomes of women attending for pre-conception counselling at the Sheffield combined obstetric and rheumatology clinic, 2002 to 2013

Ruth Smith - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Screening for diabetes and steroid-induced hyperglycaemia in patients with rheumatoid arthritis is done poorly

Alastair L Hepburn - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

Prednisolone

Clinical commissioning groups and rheumatology services: just part of MSK?

Hasnain K Hashim - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is there an ethnic variation in acceptance of biologic therapy among axial spondyloathropathy patients? A university teaching hospital experience

Haresh Selvaskandan - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A longitudinal analysis of prevalence of sustained remission and low disease activity in rheumatoid arthritis patients treated with anti-tumour necrosis factor: an analysis of the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Philip D H Hamann - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Cardiac sarcoidosis identified on MRI or PET-CT

Ella Daniels - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac sarcoidosis

N/A

Macrophage activation syndrome as a complication of adult onset Still's disease: a case series

Trixy David - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Macrophage activation syndrome

Anakinra

Takayasu arteritis: a case series of unusual complications and comorbidities

Christopher D Box - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Takayasu arteritis

N/A

The use of tumour necrosis factor inhibitors in disease modifying anti rheumatic drug-resistant inflammatory monoarthritis of the knee

Taqdees Suhail - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

Hydroxychloroquine

Periodic fever syndrome (hyper IgD syndrome) presenting with pericardial effusion in adulthood

Muhammad F Kazmi - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Hyperimmunoglobulinemia D and periodic fever syndrome

N/A

Pulmonary renal syndrome in Henoch-Schönlein purpura: a life-threatening complication

Katherine Clarke - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gastrointestinal bleeding

Cyclophosphamide

Idiopathic granulomatous mastitis: a challenging problem in rheumatology practice

Nilesh Nolkha - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Angiotensin II

Giant cell arteritis without headaches presenting as a posterior circulation stroke

Megan Rutter - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Giant cell arteritis

Methylprednisolone

Takayasu's arteritis or cocaine induced vasculitis? A case of severe necrotic orofacial and scalp ulceration

Laura Chadwick - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Takayasu arteritis

N/A

Is It still Still's?

Cathy Donaghy - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Adult onset Still's disease

Methotrexate

Copyright © 2026. QuantiNova All rights reserved